Showing results (1901-1910 of 2,407) with videos related to

Sort By:
Pageof 241
Future Medicinal Chemistry|February 15, 2022
Combining structure-based and 3D QSAR pharmacophore models to discover diverse ligands against EGFR in oral cancerPurbali Chakraborty, Sajeli Begum Ahil, Trinath Jamma, et al.
Future Medicinal Chemistry|June 5, 2019
The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotectionCharalampos Loutradis, Eirini Papadopoulou, Marietta Theodorakopoulou, et al.
Future Medicinal Chemistry|June 5, 2019
Targeting uracil-DNA glycosylases for therapeutic outcomes using insights from virus evolutionRenos Savva
Future Medicinal Chemistry|October 12, 2021
A novel multi-target strategy to attenuate the progression of Parkinson's disease by diamine hybrid AGE/ALE inhibitorN André Sasaki, Pascal Sonnet
Future Medicinal Chemistry|October 21, 2021
Identification of a novel antifungal backbone of naphthalimide thiazoles with synergistic potential for chemical and dynamic treatmentPeng-Li Zhang, Gopala Lavanya, Yang Yu, et al.
Future Medicinal Chemistry|October 26, 2021
Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agentsYingdong Cao, Hong Lu
Future Medicinal Chemistry|March 24, 2022
GANT61 elevates chemosensitivity to cisplatin through regulating the Hedgehog, AMPK and cAMP pathways in ovarian cancerPengfeng Zhu, Li Wang, Peizhen Xu, et al.
Future Medicinal Chemistry|June 27, 2019
Permeability prediction for zwitterions via chromatographic indexes and classification into 'certain' and 'uncertain'Francesco Caudana, Giuseppe Ermondi, Maura Vallaro, et al.
Future Medicinal Chemistry|April 18, 2019
Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agentsSahar Hasim, Jeffrey J Coleman
Future Medicinal Chemistry|March 8, 2022
Dual-target inhibitors based on PARP1: new trend in the development of anticancer researchJun Ge, Yu Yin, Yingpeng Li, et al.
Pageof 241